From Structure to Strategy

In this episode of The Quantum Leap, Dr. Nirdosh Jagota transitions from foundational scientific discovery to real-world application, examining how breakthroughs like AlphaFold are being translated into commercial drug design platforms. The focus is on Isomorphic Labs, the AI-driven company emerging from Alphabet, which represents a pivotal shift in how therapeutics are conceived, engineered, and developed.

Dr. Jagota provides an in-depth analysis of the Isomorphic Drug Design Engine (IsoDDE)—a next-generation AI platform designed to move beyond structural prediction into functional drug creation. He explores key capabilities including binding affinity prediction, cryptic pocket identification, and advanced antibody design, each of which addresses longstanding challenges in medicinal chemistry and molecular engineering.

The episode also evaluates the strategic significance of Isomorphic Labs’ multi-billion-dollar partnerships with Eli Lilly and Novartis, marking a defining moment where AI-driven discovery transitions from experimental promise to commercial reality. Dr. Jagota discusses how this convergence of Big Tech and Big Pharma is reshaping industry dynamics, investment strategies, and the competitive landscape of drug development.

By connecting technological innovation with business strategy, this episode illustrates how AI is transforming drug discovery from a linear, uncertain process into a data-driven, predictive, and scalable system, bringing the vision of “designing drugs at the click of a button” closer to reality.

For deeper insights, strategic perspectives, and Dr. Jagota’s ongoing work in AI-driven life sciences, please visit: 🌐 https://nirdoshjagota.us/

🌐 https://nirdoshjagota.net/

🌐 https://nirdoshjagota.com/

🌐 https://aboutnirdoshjagota.com/

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(12)

The Quantum Doctor

In this episode of The Quantum Leap, Dr. Nirdosh Jagota explores how quantum computing could move beyond pharmaceutical research and into hospitals, diagnostics, genomics, and personalized patient car...

24 Heinä 8min

Solving the Unsolvable

In this episode of The Quantum Leap, Dr. Nirdosh Jagota explores one of the most exciting frontiers in pharmaceutical innovation: quantum simulation. Building on the foundation of quantum computing in...

24 Heinä 9min

The Quantum Dawn

In this milestone episode of The Quantum Leap, Dr. Nirdosh Jagota introduces one of the most transformative technologies on the horizon: quantum computing. As artificial intelligence continues to resh...

15 Kesä 8min

The New AI Scientist

In this episode of The Quantum Leap, Dr. Nirdosh Jagota explores one of the most profound shifts in the history of scientific discovery: the emergence of AI as an active research partner. Moving beyon...

15 Kesä 9min

The Billion-Dollar Question

In this episode of The Quantum Leap, Dr. Nirdosh Jagota steps beyond the science of AI and quantum computing to explore the financial forces driving the future of medicine. As billions of dollars flow...

3 Kesä 12min

The Automated Chemist

In this episode of The Quantum Leap, Dr. Nirdosh Jagota explores one of the most exciting frontiers in pharmaceutical innovation: the emergence of the self-driving laboratory. While artificial intelli...

3 Kesä 12min

Mapping Biology at Scale

In this episode of The Quantum Leap, Dr. Nirdosh Jagota explores a fundamental shift in drug discovery—from traditional target-based approaches to a data-first, phenotypic discovery model powered by a...

28 Huhti 7min

The Digital Patient

In this episode of The Quantum Leap, Dr. Nirdosh Jagota shifts the focus from molecules to one of the most critical elements in drug development—the patient. He explores how artificial intelligence is...

28 Huhti 7min